In fact, to treat insulin resistance in these patients, for the past year, we have also been using one of the first drugs of the GLP-1 RA family that was introduced for the treatment of diabetes about 20 years ago in Italy; at the time, it was considered an innovative therapy with promising properties because improvements in glucose control were often accompanied by a reduction in bodyweight [22,23]. Here, GCG is linked to Insulin resistance.